Template:Neonatal HSV antivirals: Difference between revisions

No edit summary
(Convert to AntibioticDose with disease=Meningitis for SMW linking)
 
Line 1: Line 1:
*[[Acyclovir]] 20 mg/kg IV every 8 hours (duration depends on classification)
*{{AntibioticDose|disease=Meningitis|drug=Acyclovir|dose=20mg/kg IV q8hrs|context=Neonatal HSV duration depends on classification|population=Pediatric}}
*If ocular involvement:
*If ocular involvement:
**1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
**1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
**Optho consult
**Optho consult
*As for any febrile neonate SBI evaluation:
*As for any febrile neonate SBI evaluation:
**[[Ampicillin]] + [[gentamycin]]
**{{AntibioticDose|disease=Meningitis|drug=Ampicillin|dose=see age-based dosing|context=Neonatal HSV with SBI evaluation|population=Pediatric}} + [[Gentamicin]]
***May substitute [[gentamycin]] with [[cefotaxime]]/[[ceftazidime]]
***May substitute [[Gentamicin]] with [[Cefotaxime]]/[[Ceftazidime]]

Latest revision as of 01:49, 20 March 2026